The EPiTOMISE study – an RCT of malaria chemoprevention in children with sickle cell anemia in Homa Bay, Kenya – has enrolled 25% of our target enrollment of 246. The first patient was enrolled in January 2018.

Congratulations to the crack study team operating at Homa Bay County Hospital for successfully recruiting these children and ensuring they receive great care through the study protocol.